Literature DB >> 31243026

Rare case of Bing-Neel syndrome treated successfully with ibrutinib.

Hamza Hashmi1, Jugraj Singh Dhanoa2, Robert Emmons3.   

Abstract

Waldenstrom's macroglobulinaemia (WM) is a lymphoproliferative disorder of the B cell origin. It is characterised by the presence of IgM paraprotein in the serum and lymphoplasmacytic lymphoma cells in the bone marrow with extranodal involvement relatively uncommon. Bing-Neel syndrome (BNS) is a neurological complication of WM that results from infiltration of the central nervous system by malignant lymphoplasmacytic cells. We present an interesting case of BNS that responded remarkably to ibrutinib monotherapy. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chemotherapy; haematology (incl blood transfusion); medical management

Mesh：

Substances：

Year:  2019        PMID： 31243026      PMCID： PMC6605891          DOI： 10.1136/bcr-2019-230067

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  9 in total

Review 1.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Authors:  Roger G Owen; Steven P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesus F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

2.  Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.

Authors:  Christopher Mason; Steven Savona; Josephine N Rini; Jorge J Castillo; Lian Xu; Zachary R Hunter; Steven P Treon; Steven L Allen
Journal:  Br J Haematol       Date:  2016-07-13       Impact factor: 6.998

3.  Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

Authors:  Jorge J Castillo; Shirley D'Sa; Michael P Lunn; Monique C Minnema; Alessandra Tedeschi; Frederick Lansigan; M Lia Palomba; Marzia Varettoni; Ramon Garcia-Sanz; Lakshmi Nayak; Eudocia Q Lee; Mikael L Rinne; Andrew D Norden; Irene M Ghobrial; Steven P Treon
Journal:  Br J Haematol       Date:  2015-12-21       Impact factor: 6.998

4.  Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.

Authors:  Jorge J Castillo; Gilad Itchaki; Jonas Paludo; Marzia Varettoni; Christian Buske; Toby A Eyre; Julio C Chavez; Kenneth H Shain; Samar Issa; M Lia Palomba; Oren Pasvolsky; David Simpson; Dipti Talaulikar; Constantine S Tam; Alessandra Tedeschi; Stephen M Ansell; Lakshmi Nayak; Steven P Treon
Journal:  Blood       Date:  2018-12-06       Impact factor: 22.113

Review 5.  Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).

Authors:  Laurence Simon; Aikaterini Fitsiori; Richard Lemal; Jehan Dupuis; Benjamin Carpentier; Laurys Boudin; Anne Corby; Thérèse Aurran-Schleinitz; Lauris Gastaud; Alexis Talbot; Stéphane Leprêtre; Béatrice Mahe; Camille Payet; Carole Soussain; Charlotte Bonnet; Laure Vincent; Séverine Lissandre; Raoul Herbrecht; Stéphane Kremer; Véronique Leblond; Luc-Matthieu Fornecker
Journal:  Haematologica       Date:  2015-09-18       Impact factor: 9.941

6.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Authors:  Lian Xu; Zachary R Hunter; Guang Yang; Yangsheng Zhou; Yang Cao; Xia Liu; Enrica Morra; Alessandra Trojani; Antonino Greco; Luca Arcaini; Marzia Varettoni; Maria Varettoni; Jennifer R Brown; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi; Christopher J Patterson; Robert J Manning; Christina K Tripsas; Neal I Lindeman; Steven P Treon
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

7.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

8.  MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.

Authors:  Stéphanie Poulain; Eileen M Boyle; Christophe Roumier; Hélène Demarquette; Mathieu Wemeau; Sandrine Geffroy; Charles Herbaux; Elisabeth Bertrand; Bénédicte Hivert; Louis Terriou; Albert Verrier; Jean Paul Pollet; Claude Alain Maurage; Brigitte Onraed; Franck Morschhauser; Bruno Quesnel; Patrick Duthilleul; Claude Preudhomme; Xavier Leleu
Journal:  Br J Haematol       Date:  2014-08-27       Impact factor: 6.998

9.  Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.

Authors:  Steven P Treon; Joshua Gustine; Kirsten Meid; Guang Yang; Lian Xu; Xia Liu; Maria Demos; Amanda Kofides; Nicholas Tsakmaklis; Jiaji G Chen; Manit Munshi; Gloria Chan; Toni Dubeau; Noopur Raje; Andrew Yee; Elizabeth O'Donnell; Zachary R Hunter; Jorge J Castillo
Journal:  J Clin Oncol       Date:  2018-07-25       Impact factor: 44.544
  9 in total
  3 in total

1.  Primary central nervous system diffuse large B-cell lymphoma masqueraded as Bing-Neel syndrome: Steps in management and review of future directions.

Authors:  Lukas Delasos; Deep Phachu; Nishka Shetty; Melissa Sepulveda-Ramos; James Vredenburgh
Journal:  Clin Case Rep       Date:  2021-12-06

Review 2.  Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First.

Authors:  Anagha Deshpande; Javier Munoz
Journal:  Ther Clin Risk Manag       Date:  2022-06-23       Impact factor: 2.755

Review 3.  Rare central nervous system lymphomas.

Authors:  Furqaan Ahmed Kaji; Nicolás Martinez-Calle; Vishakha Sovani; Christopher Paul Fox
Journal:  Br J Haematol       Date:  2022-03-16       Impact factor: 8.615
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.